Keybanc analyst Matthew Mishan maintains Steris (NYSE:STE) with a Overweight and raises the price target from $254 to $258.
Keybanc Maintains Overweight on Steris, Raises Price Target to $258
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.